A carregar...
Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 10−15% of all lung cancers. The prognosis is poor with median survival in the advanced stage remaining at around 12 months. Despite applying every known therapeutic approach, no major breakthrough has improved the overall survival in...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MDPI AG
2019-10-01
|
Colecção: | Cancers |
Assuntos: | |
Acesso em linha: | https://www.mdpi.com/2072-6694/11/10/1570 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|